Market Cap ₹23 Cr.
Stock P/E 0.0
P/B -
Current Price ₹5.2
Book Value ₹ 0
Face Value 10
52W High ₹14.4
Dividend Yield 0%
52W Low ₹ 5.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 246 | 95 | 105 | 116 | 150 | 129 | 163 | 183 | 134 | 67 |
Other Income | 8 | 10 | 2 | 16 | 5 | 7 | 7 | 11 | 51 | 11 |
Total Income | 254 | 105 | 107 | 132 | 156 | 136 | 170 | 194 | 184 | 78 |
Total Expenditure | 180 | 92 | 110 | 109 | 111 | 113 | 140 | 139 | 102 | 78 |
Operating Profit | 74 | 14 | -3 | 24 | 45 | 23 | 31 | 54 | 82 | -1 |
Interest | 25 | 25 | 25 | 25 | 24 | 23 | 20 | 21 | 15 | 15 |
Depreciation | 45 | 44 | 41 | 40 | 40 | 42 | 38 | 38 | 19 | 14 |
Exceptional Income / Expenses | -18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -672 | 0 |
Profit Before Tax | -15 | -55 | -69 | -41 | -19 | -43 | -27 | -4 | -624 | -30 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -15 | -55 | -69 | -41 | -19 | -43 | -27 | -4 | -624 | -30 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
Profit After Adjustments | -15 | -55 | -69 | -41 | -19 | -43 | -27 | -4 | -624 | -30 |
Adjusted Earnings Per Share | -3.3 | -12.6 | -15.7 | -9.4 | -4.3 | -9.7 | -6.1 | -1 | -142.2 | -6.8 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM |
---|---|---|---|---|---|
Net Sales | 938 | 1228 | 1141 | 466 | 547 |
Other Income | 13 | 6 | 20 | 34 | 80 |
Total Income | 950 | 1234 | 1161 | 500 | 626 |
Total Expenditure | 854 | 1107 | 888 | 421 | 459 |
Operating Profit | 97 | 127 | 273 | 79 | 166 |
Interest | 16 | 18 | 81 | 98 | 71 |
Depreciation | 50 | 45 | 166 | 165 | 109 |
Exceptional Income / Expenses | 0 | 0 | -15 | 0 | -672 |
Profit Before Tax | 31 | 64 | 11 | -184 | -685 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 31 | 64 | 11 | -184 | -685 |
Adjustments | -1 | -2 | -17 | 0 | 0 |
Profit After Adjustments | 30 | 62 | -6 | -184 | -685 |
Adjusted Earnings Per Share | 7.6 | 15.4 | -1.3 | -42 | -156.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -59% | -21% | 0% | 0% |
Operating Profit CAGR | -71% | -7% | 0% | 0% |
PAT CAGR | -1773% | NAN% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -57% | -58% | -61% | NA% |
ROE Average | -29% | -5% | -2% | -2% |
ROCE Average | -7% | 5% | 6% | 6% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|
Shareholder's Funds | 480 | 542 | 743 | 558 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 25 | 208 | 342 | 417 |
Other Non-Current Liabilities | 6 | 6 | 267 | 216 |
Total Current Liabilities | 261 | 371 | 698 | 594 |
Total Liabilities | 773 | 1126 | 2049 | 1786 |
Fixed Assets | 318 | 420 | 834 | 698 |
Other Non-Current Assets | 89 | 192 | 158 | 68 |
Total Current Assets | 365 | 515 | 1057 | 1020 |
Total Assets | 773 | 1126 | 2049 | 1786 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 53 | 80 | 119 | 3 |
Cash Flow from Operating Activities | 93 | 64 | -192 | 207 |
Cash Flow from Investing Activities | 91 | -182 | -331 | 0 |
Cash Flow from Financing Activities | -156 | 163 | 408 | -208 |
Net Cash Inflow / Outflow | 27 | 46 | -116 | -0 |
Closing Cash & Cash Equivalent | 80 | 125 | 3 | 3 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|
Earnings Per Share (Rs) | 7.61 | 15.35 | -1.31 | -42.01 |
CEPS(Rs) | 20.15 | 27.21 | 40.36 | -4.34 |
DPS(Rs) | 1 | 1.25 | 0 | 0 |
Book NAV/Share(Rs) | 119.46 | 134.09 | 168.1 | 125.98 |
Core EBITDA Margin(%) | 8.97 | 9.86 | 22.14 | 9.75 |
EBIT Margin(%) | 5.02 | 6.63 | 8.05 | -18.44 |
Pre Tax Margin(%) | 3.31 | 5.18 | 0.97 | -39.53 |
PAT Margin (%) | 3.31 | 5.18 | 0.97 | -39.53 |
Cash Profit Margin (%) | 8.61 | 8.88 | 15.52 | -4.08 |
ROA(%) | 4.02 | 6.7 | 0.69 | -9.61 |
ROE(%) | 6.49 | 12.53 | 1.73 | -28.57 |
ROCE(%) | 9.16 | 12.8 | 8.94 | -7.26 |
Receivable days | 101.04 | 93.63 | 189.69 | 606.94 |
Inventory Days | 0 | 1.64 | 1.45 | 2.3 |
Payable days | 0 | 0 | 0 | 0 |
PER(x) | 87.15 | 38.44 | 0 | 0 |
Price/Book(x) | 5.55 | 4.4 | 0.62 | 0.5 |
Dividend Yield(%) | 0.15 | 0.21 | 0 | 0 |
EV/Net Sales(x) | 2.78 | 2 | 0.88 | 1.7 |
EV/Core EBITDA(x) | 26.98 | 19.37 | 3.7 | 9.98 |
Net Sales Growth(%) | 0 | 30.99 | -7.12 | -59.12 |
EBIT Growth(%) | 0 | 73.23 | 12.71 | -193.63 |
PAT Growth(%) | 0 | 104.97 | -82.68 | -1772.43 |
EPS Growth(%) | 0 | 101.8 | -108.51 | -3116.81 |
Debt/Equity(x) | 0.07 | 0.41 | 0.75 | 0.94 |
Current Ratio(x) | 1.4 | 1.39 | 1.52 | 1.72 |
Quick Ratio(x) | 1.4 | 1.37 | 1.51 | 1.71 |
Interest Cover(x) | 2.94 | 4.56 | 1.14 | -0.87 |
Total Debt/Mcap(x) | 0.01 | 0.09 | 1.2 | 1.87 |
# | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 47.89 | 47.89 | 23.39 | 23.39 | 23.09 | 23.09 | 23.09 | 23.09 | 22.62 | 21.95 |
FII | 3.09 | 3.09 | 0.02 | 0.02 | 0 | 0 | 0.01 | 0 | 0 | 0 |
DII | 15.33 | 13.02 | 0.82 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
Public | 33.69 | 36.01 | 75.77 | 76.53 | 76.85 | 76.85 | 76.85 | 76.85 | 77.32 | 77.99 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.1 | 2.1 | 1.03 | 1.03 | 1.01 | 1.01 | 1.01 | 1.01 | 0.99 | 0.96 |
FII | 0.14 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.67 | 0.57 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 1.48 | 1.58 | 3.32 | 3.36 | 3.37 | 3.37 | 3.37 | 3.37 | 3.39 | 3.42 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About